This is obnoxious when companies do this. Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) is trying the hat trick where it changes exchange listings. Now the company plans to transfer the ADR listing…
Jon C. Ogg The three major US stock indexes opened slightly higher this morning, but the DJIA almost immediately turned south and remained in negative territory all session. The Nasdaq composite and S&P 500 turned…
Wednesday is a fairly busy day for earnings expectations. We are expecting the following reports: Abercrombie & Fitch Co. (NYSE: ANF); Agilent Technologies, Inc. (NYSE: A); Blue Nile Inc. (NASDAQ: NILE); Clearwire Corporation…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms this Monday morning. AeroVironment, Inc. (NASDAQ: AVAV) Raised to Buy at Goldman…
The tide of patent expirations that is washing over big pharmaceutical houses is cresting now and investors have begun looking forward to how these companies will deal with some sharp blows to…
Teva Pharmaceutical Industries Limited (NASDAQ: TEVA) had a rough 2011. If the pre-market trading indications manage to last throughout the day, then it appears that Teva could be off to a great…
Jon C. Ogg US equity markets opened a bit higher this morning, after futures trading pared early morning gains. Early optimism, however, was not to pan out, following some rather downbeat remarks from the president…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Monday morning. AK Steel Holding Corporation (NYSE: AKS) Raised to Outperform from Market…
We recently gave a full review of the DJIA components we expect to raise their dividend payouts in the weeks and months ahead. Among those we expect to raise the dividend is…
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Friday morning. Arch Coal, Inc. (NYSE: ACI) named as Bear of the Day with…
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) has had its share of trouble in 2011, but perhaps the expiring patent on that statin Lipitor by Pfizer Inc. (NYSE: PFE) may offer some reprieve. …
It has been a long time coming, and now many patients will be able to switch to a generic. Pfizer Inc. (NYSE: PFE) has now officially lost its patent over its cholesterol-lowering…
Pfizer Inc. (NYSE: PFE) has a big day ahead of it. While it has been known for years, it is a massive date: Lipitor goes off-patent and will have generic versions of…
Paulson & Co. Inc. is another hedge fund group that investors use for Whale Watching, although this last quarter was not exactly kind to Mr. Paulson’s billions… The current 13F report shows…
Each morning 24/7 Wall St. issues a summary list of key analyst upgrades, downgrades, and initiations issued by Wall Street research firms. We review these calls and other calls made throughout the…
